Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MelCancerVac in Advanced Colorectal Cancer
NCT00311272Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- Nov 2004
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MelCancerVac in colorectal cancer (CRC), sponsored by Gentofte Hospital. Started Nov 2004; status: completed.
02
Drugs
MelCancerVac
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00311272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311272.